UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036795
Receipt number R000041927
Scientific Title Relation of frailty and quality of life in continuing treatment of elderly gastroenterological cancer patient
Date of disclosure of the study information 2019/06/12
Last modified on 2020/05/25 16:53:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relation of frailty and quality of life in continuing treatment of elderly gastroenterological cancer patient

Acronym

Relation of frailty and quality of life in continuing treatment of elderly gastroenterological cancer patient

Scientific Title

Relation of frailty and quality of life in continuing treatment of elderly gastroenterological cancer patient

Scientific Title:Acronym

Relation of frailty and quality of life in continuing treatment of elderly gastroenterological cancer patient

Region

Japan


Condition

Condition

gastroenterological cancer

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the relationship between frailty and quality of life when changing chemotherapy regimens for patients with gastroenterological cancer

Basic objectives2

Others

Basic objectives -Others

The relationships between Frailty, QOL,and Chemotherapy Adverse Events

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Frailty State, Geriatric 8 (G8) Score

Key secondary outcomes

(1) Degree of adverse events Measure with PRO-CTCAE
(2) QOL degree EQ-D5-L5 score


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Elderly person 65 years of age or more
(2) Patients with stage II to stage IV gastroenterological cancer
(stomach, colon, pancreas, biliary tract cancer etc.)
(3) Patient who have changed the currently received regimen and have started a new regimen
(4) Patient who is judged by primary doctor determines that investigation cooperation is possible physically and mentally
(5) Patient who gained consent to participate in research

Key exclusion criteria

(1) Patient shall not have dementia or its previous history
(2) Those who cannot understand Japanese to complete the questionnaire

Target sample size

130


Research contact person

Name of lead principal investigator

1st name Hiroko
Middle name
Last name Komatsu

Organization

Keio University Graduate School of Health Management

Division name

Nursing

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582

TEL

03-5363-3733

Email

komah@sfc.keio.ac.jp


Public contact

Name of contact person

1st name Hironori
Middle name
Last name Oohinata

Organization

Keio University Graduate School of Health Management

Division name

Nursing

Zip code

252-0883

Address

4411 Endo, Fujisawa-shi, Kanagawa 252-0883

TEL

0466-49-6265

Homepage URL


Email

h18704ho@sfc.keio.ac.jp


Sponsor or person

Institute

Keio University Graduate School of Health Management

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee

Address

35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院


Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 04 Month 24 Day

Date of IRB

2019 Year 04 Month 24 Day

Anticipated trial start date

2019 Year 06 Month 10 Day

Last follow-up date

2019 Year 11 Month 30 Day

Date of closure to data entry

2020 Year 03 Month 30 Day

Date trial data considered complete

2020 Year 03 Month 31 Day

Date analysis concluded



Other

Other related information

Design: Observational cross-sectional study
Measures
1)Status of residence
2)Instrumental Activities of Daily Living
3)Degree of adverse events of chemotherapy
4)Quality of life
5)Charlson Comorbidity Index
6)Frailty index
7)Measurement of the calf


Management information

Registered date

2019 Year 05 Month 20 Day

Last modified on

2020 Year 05 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041927


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name